• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• For Supporters

“Philanthropists will be younger and more diverse, and will want to see more evidence”: Chris Gethin on the future of major giving

Director of Philanthropy, Chris Gethin, shares his thoughts on what major giving will look like in 10 years’ time Director of Philanthropy, Chris Gethin, shares his thoughts on what major giving will look like in 10 years’ time

7 February 2020

• For Supporters

Partner Revolut is making donating easier than ever

To celebrate World Cancer Day, we explore how the FinTech company and some of our other partners are supporting the campaign To celebrate World Cancer Day, we explore how the FinTech company and some of our other partners are supporting the campaign

3 February 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

NHS staff shortages mean patients miss out on early bowel cancer diagnosis

Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages. Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages.

28 January 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020

• Science & Technology

Magnetised molecules used to monitor breast cancer

Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer. Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer.

20 January 2020

• For Supporters

View from the board: What's in store for Cancer Research UK in 2020

As we start not only a new year but a new decade, we asked some of Cancer Research UK’s Executive Board what they are most looking forward to in 2020… As we start not only a new year but a new decade, we asked some of Cancer Research UK’s Executive Board what they are most looking forward to in 2020…

17 January 2020

• For Supporters

Introducing Trailblazers – our new philanthropic initiative to back research’s rising stars

We investigate how a new philanthropic programme is offering a flying start to early-career scientists We investigate how a new philanthropic programme is offering a flying start to early-career scientists

10 January 2020

• Health & Medicine

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer. Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer.

6 January 2020

• For Supporters

In conversation with our Chair, Sir Borys – Part two: From lab to leadership

Professor Sir Leszek Borysiewicz, speaks about how a diverse CV has helped him navigate chairmanship of the world’s largest cancer charity Professor Sir Leszek Borysiewicz, speaks about how a diverse CV has helped him navigate chairmanship of the world’s largest cancer charity

20 December 2019